Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Material Reconciliation During Tablet Manufacturing – V 2.0

Posted on By

Tablets: SOP for Material Reconciliation During Tablet Manufacturing – V 2.0

Standard Operating Procedure for Material Reconciliation During Tablet Manufacturing

Department Tablet
SOP No. SOP/TAB/184/2025
Supersedes SOP/TAB/184/2022
Page No. Page 1 of 6
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

To establish the procedures for material reconciliation during tablet manufacturing to ensure accurate tracking of all materials used in the production process and ensure compliance with regulatory requirements.

2. Scope

This SOP applies to all materials used in the tablet manufacturing process, including active pharmaceutical ingredients (APIs), excipients, and packaging materials. It covers material usage, wastage, and inventory reconciliation from the start of production to the final product.

3. Responsibilities

  • Quality Assurance (QA): Responsible for overseeing material reconciliation processes, ensuring that all materials used are properly accounted for, and discrepancies are investigated.
  • Production Team: Responsible for providing accurate records of materials used, quantities, and wastage, and for reporting any discrepancies in material usage.
  • Warehouse Team: Responsible for ensuring that materials are accurately stocked and that proper documentation is maintained for material transfers.
  • Inventory Control: Responsible for maintaining the records of raw materials and finished goods, ensuring that any discrepancies in material quantities are identified and investigated.

4. Accountability

The

QA Manager is accountable for ensuring that the material reconciliation process is followed accurately, that discrepancies are resolved promptly, and that accurate records are maintained throughout the production process.

See also  Tablets: SOP for Intermediate Precision Testing for Tablets - V 2.0

5. Procedure

5.1 Material Issuance

  1. Ensure that all materials required for production are issued according to the material requisition form.
  2. Verify the quantities of raw materials, APIs, excipients, and packaging materials against the requisition list and update the inventory system accordingly.
  3. Record the issued material details, including batch numbers, quantities, and any other relevant data in the material usage log (Annexure-1).
  4. Ensure that materials are issued in accordance with the production schedule and that any changes are properly documented.

5.2 Material Usage Monitoring

  1. During tablet manufacturing, monitor and record the actual quantities of materials used in the production process.
  2. Note any wastage or rework materials generated during the process, and document the reasons for these discrepancies (e.g., process loss, machine issues) (Annexure-2).
  3. Ensure that wastage is within acceptable limits, and if it exceeds the defined threshold, investigate the cause and take corrective actions.

5.3 Material Reconciliation

  1. After each production batch is completed, perform a reconciliation of the materials used with the original quantities issued.
  2. Compare the quantities of raw materials used, wastage, and final tablet production against the quantities issued and update the inventory accordingly.
  3. Calculate the material yield, which should account for all usage, wastage, and final product yield. Any significant discrepancies must be investigated (Annexure-3).
  4. If there are discrepancies between the quantities issued and the quantities used, notify QA and investigate the potential causes, including issues such as measurement errors, incorrect material issues, or process inefficiencies.
See also  Tablets: SOP for Multi-Layer Tablet Manufacturing Process - V 2.0

5.4 Discrepancy Investigation

  1. If discrepancies in material usage or wastage are identified, conduct an investigation to determine the root cause.
  2. Review all material handling, storage, and manufacturing records to identify potential areas for improvement.
  3. Investigate any discrepancies in the issuance process, including whether the correct quantities were issued or if there was an error in the material receipt process (Annexure-4).
  4. Investigate any potential operational issues, such as incorrect weighing or measuring of materials, process losses, or equipment malfunctions.
  5. Corrective actions should be taken to address the root cause of any discrepancies and prevent recurrence.

5.5 Documentation and Record Keeping

  1. Maintain accurate records of material usage, wastage, and reconciliation for each production batch (Annexure-1, Annexure-2, Annexure-3, and Annexure-4).
  2. Ensure all records are signed and dated by the responsible personnel to confirm the accuracy of the information.
  3. Store all material reconciliation records securely and retain them for at least five years or as required by regulatory guidelines.

5.6 Reporting

  1. Report material discrepancies and corrective actions taken to senior management for review and decision-making.
  2. Provide quarterly reports on material reconciliation and any corrective actions taken to ensure ongoing compliance with material management procedures.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • RPN: Risk Priority Number
  • CAPA: Corrective and Preventive Action
See also  Tablets: SOP for Tablet Temperature Control During Compression - V 2.0

7. Documents

  1. Material Usage Log (Annexure-1)
  2. Material Wastage Log (Annexure-2)
  3. Material Reconciliation Report (Annexure-3)
  4. Discrepancy Investigation Report (Annexure-4)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • ISO 9001 – Quality Management Systems
  • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Material Usage Log

Batch Number Material Name Quantity Issued Quantity Used Wastage
Batch-12345 API-123 1000 kg 980 kg 20 kg

Annexure-2: Material Wastage Log

Batch Number Material Name Wastage Reason Wastage Quantity
Batch-12345 API-123 Process Loss 20 kg

Annexure-3: Material Reconciliation Report

Batch Number Material Name Issued Quantity Used Quantity Reconciliation Status
Batch-12345 API-123 1000 kg 980 kg Reconciled

Annexure-4: Discrepancy Investigation Report

Batch Number Discrepancy Description Investigation Findings Corrective Actions Completion Date
Batch-12345 Discrepancy in material usage Measurement error during production Re-calibrated equipment and retrained personnel 15/04/2026

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated material reconciliation process Improved tracking and reporting of discrepancies QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: Aerosol: SOP for Review and Approval of Batch Manufacturing Records – V 2.0
Next Post: Capsule: SOP for Process Validation of Capsule Filling Operations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version